Thromb Haemost 2003; 90(01): 27-35
DOI: 10.1055/s-0037-1613595
Review Article
Schattauer GmbH

Quality of life in venous disease

Inez van Korlaar
1   Unit of Psychology, Leiden University Medical Center, Leiden, The Netherlands
,
Carla Vossen
1   Unit of Psychology, Leiden University Medical Center, Leiden, The Netherlands
,
Frits Rosendaal
1   Unit of Psychology, Leiden University Medical Center, Leiden, The Netherlands
1   Unit of Psychology, Leiden University Medical Center, Leiden, The Netherlands
,
Linda Cameron
1   Unit of Psychology, Leiden University Medical Center, Leiden, The Netherlands
,
Edwin Bovill
1   Unit of Psychology, Leiden University Medical Center, Leiden, The Netherlands
,
Adrian Kaptein
1   Unit of Psychology, Leiden University Medical Center, Leiden, The Netherlands
› Author Affiliations
Financial support: This research was supported by the NIH (grant PHS PO1 HL-46703-P2Y11), and by BIOMED II grant: BMHI-CT94-1565
Further Information

Publication History

Received 21 November 2002

Accepted after revision 07 April 2003

Publication Date:
07 December 2017 (online)

Summary

Quality of life (QOL) can be defined as the functional effect of an illness and its consequent therapy upon a patient, as perceived by the patient. Studies on the impact of chronic venous disease on quality of life are scarce compared to quality of life research in other diseases. The purpose of this paper was to describe instruments that assess the quality of life in patients with chronic venous disease and to review the literature on this topic.

A computer search of the MedLine database was performed to identify papers; the bibliographies of relevant articles were reviewed to obtain additional papers. Papers were included if they described the development or use of a quality of life instrument for patients with chronic venous disease.

A total of 25 papers were identified that fit the inclusion criteria. The studies described in the papers used six different generic instruments and ten disease-specific instruments. Quality of life in chronic venous disease was assessed in 12 studies. Six studies compared different types of treatment for chronic venous disease where QOL was an outcome measure. Despite the wide variety of measures used, results indicate that the quality of life of patients with chronic venous disease is affected in the physical domain mostly with regard to pain, physical functioning and mobility, and that they suffer from negative emotional reactions and social isolation.

We feel that QOL should be a standard measure in future studies in patients with chronic venous disease, preferably with a combination of generic and disease-specific measures.

 
  • References

  • 1 Schipper H, Clinch J, Powell V. Definitions and conceptual issues. Quality of life Asessments in Clinical Trials. Spilker, ed. Raven Press 1990; 11-24.
  • 2 Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273: 59-65.
  • 3 Berzon RA. Understanding and using health-related quality of life instruments within clinical research studies. Quality of Life Assessment in Clinical Trials: Method and Practice. Staquet, Hays, Fayers, eds: Oxford University Press 1998; 3-15.
  • 4 Lamping DL. Clinical outcomes and quality of life. Phlebology 1999; 14 suppl. 1: 43-51.
  • 5 Bowling A. Measuring Health: A Review of Quality of Life Measurement Scales. Philadelphia: Open University Press; 1997
  • 6 Bowling A. Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales. Philadelphia: Open University Press; 2001
  • 7 Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-333.
  • 8 Bland JM, Altman DG. Cronbach’s alpha. BMJ 1997; 314: 572.
  • 9 Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. 1993. Boston, The Health Institute; New England Medical Center.:
  • 10 Garratt A, Schmidt L, Mackintosh A. et al. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002; 324: 1417-21.
  • 11 Kahn SR, Hirsch A, Shrier I. Effect of post-thrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162: 1144-8.
  • 12 Smith JJ, Guest MG, Greenhalgh RM. et al. Measuring the quality of life in patients with venous ulcers. J Vasc Surg 2000; 31: 642-9.
  • 13 Walters SJ, Morrell CJ, Dixon S. Measuring health-related quality of life in patients with venous leg ulcers. Qual Life Res 1999; 8: 327-36.
  • 14 Garratt AM, Macdonald LM, Ruta DA. et al. Towards measurement of outcome for patients with varicose veins. Qual Health Care 1993; 2: 5-10.
  • 15 Kurz X, Lamping DL, Kahn SR. et al. Do varicose veins affect quality of life? Results of an international population-based study. J Vasc Surg 2001; 34: 641-8.
  • 16 O&Brien B, Levine M, Willan A. et al. Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis. Arch Intern Med 1999; 159: 2298-2304.
  • 17 Koopman MM, Prandoni P, Piovella F. et al. Treatment of venous thrombosis with intrave-nous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996; 334: 682-7.
  • 18 Comerota AJ, Throm RC, Mathias SD. et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000; 32: 130-7.
  • 19 Beyth RJ, Cohen AM, Landefeld CS. Longterm outcomes of deep-vein thrombosis. Arch Intern Med 1995; 155: 1031-7.
  • 20 Hunt SM, McEwan J, McKenna SP. Measuring Health Status. Beckenham: Croom Helm; 1986
  • 21 Franks PJ, Moffatt CJ. Health related quality of life in patients with venous ulceration: use of the Nottingham Health Profile. Qual Life Res 2001; 10: 693-700.
  • 22 Lindholm C, Bjellerup M, Christensen OB. et al. Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham Health Profile. Acta Derm Venereol 1993; 73: 440-3.
  • 23 The EuroQol group EuroQol-a facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-207.
  • 24 Melzack R. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191-7.
  • 25 Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing 1983; 12: 166-70.
  • 26 Kellner R, Sheffield BF. A self-rating scale of distress. Psychol Med 1973; 3: 88-100.
  • 27 Franks PJ, Morrell CJ, Connolly M. et al. Community leg ulcer clinics: Effect on quality of life. Phlebology 1994; 9: 83-6.
  • 28 Franks PJ, Wright DD, Fletcher AE. et al. A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. Eur J Surg 1992; 158: 149-55.
  • 29 Wood-Dauphinee S. Assessing quality of life in clinical research: from where have we come and where are we going?. J Clin Epidemiol 1999; 52: 355-63.
  • 30 Augustin M, Dieterle W, Zschocke I. et al. Development and validation of a disease-specific questionnaire on the quality of life of patients with chronic venous insufficiency. VASA 1997; 26: 291-301.
  • 31 Klyscz T, Junger M, Schanz S. et al. Quality of life in chronic venous insufficiency (CVI). Results of a study with the newly developed Tübingen Questionnaire for measuring quality of life of patients with chronic venous insufficiency] . Hautarzt 1998; 49: 372-81.
  • 32 Lamping DL, Abenhaim L, Kurz X. et al. Measuring quality of life and symptoms in chronic venous disorders of the leg: development and psychometric evaluation of the VEINES-QOL/VEINES-SYM questionnaire. Qual Life Res 1998; 7: 621-2.
  • 33 Lamping DL, Schroter S, Kurz X. et al. Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. J Vasc Surg 2003; 37: 410-9.
  • 34 Launois R, Raboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in Chronic Lower Limb Venous Insufficiency (CIVIQ). Qual Life Res 1996; 5: 539-54.
  • 35 Mathias SD, Prebil LA, Putterman CG. et al. A health-related Quality of Life Measure in patients with deep vein thrombosis: a validation study. Drug Inform J 1999; 33: 1173-87.
  • 36 Hyland ME, Ley A, Thomson B. Quality of life of leg ulcer patients: questionnaire and preliminary findings. J Wound Care 1986; 3: 294-8.
  • 37 Ziegler S, Schillinger M, Maca TH. et al. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res 2001; 101: 23-33.
  • 38 Charles H. The impact of leg ulcers on patients’ quality of life. Prof Nurse 1995; 10: 571-4.
  • 39 Phillips T, Stanton B, Provan A. et al. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994; 31: 49-53.
  • 40 Frank D, Blattler W. Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects. Schweiz Med Wochenschr 1998; 128: 1328-33.
  • 41 Gänger KH, Nachbur BH, Ris HB. et al. Surgical thrombectomy versus conservative treatment for deep venous thrombosis; functional comparison of long-term results. Eur J Vasc Surg 1989; 3: 529-38.
  • 42 Kulinna W, Ney D, Wenzel T. et al. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thromb Hemost 1999; 25: 123-6.
  • 43 Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest 1998; 113: 467-81.